eMS News

HAVE YOU BEEN DIAGNOSED WITH MS AND WISH TO PARTICIPATE IN THE STUDY OF A NEW INVESTIGATIONAL DRUG? Purpose of the Study: The purpose of this research study is to…

Many of us balk at the idea of talking about bladder issues because it can feel embarrassing or uncomfortable. And yet, it is an important topic to address, especially in…

WESTMINSTER, Colo., Jan. 15, 2014 – The Rocky Mountain Multiple Sclerosis Center announced today it has named Gina Berg as its new CEO. The Rocky Mountain MS Center is the…

Vote and help the Rocky Mountain MS Center win $300 Healthline.com named the Rocky Mountain MS Center one of the best MS nonprofits in the U.S. We need your help to…

News release from Community First Foundation ARVADA, Colo. (December 11, 2013) – Colorado donors once again united to support 1,442 nonprofit organizations during the fourth Colorado Gives Day on December…

Related Diseases: NMO In 2013, the Rocky Mountain MS Center Board of Directors expanded the mission of the MS Center to include related diseases. Patients with these diseases, which share…

Discover your Adventures Within! Adventures Within programs are custom designed retreats for people living with MS, friends and family members. Programs are offered through the Breckenridge Outdoor Education Center in…

A documentary by University of Wisconsin-Madison researcher Ian Duncan and film director Steinar Hybertsen that follows multiple sclerosis (MS) patients striving to conquer the disease through Nordic skiing will air…

Tecfidera: Sidestepping the Side Effects Physicians prescribe, and we take, medications because they have a desired effect and produce a positive outcome. For example, with MS disease-modifying therapies the positive…

Tecfidera: Clinical Trials Tecifera (previously known as BG-12), was approved by the FDA in March 2013 for relapsing-remitting forms of MS. An oral fumarate derivative, Tecfidera has been shown to…